Revenue segments as reported by the company.

Instruments & Accessories

Systems

Services

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Intuitive Surgical

Intuitive Surgical, Inc. engages in the development, manufacture, and marketing of da Vinci Surgical Systems, and related instruments and accessories for invasive surgery. Its products include Da Vinci and Ion. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Intuitive Surgical reports robust Q4 performance and eyes future growth

Intuitive Surgical's Q4 2022 showcased strong performance and growth in procedures and system placements.
While facing challenges like macroeconomic uncertainty and supply chain costs, the company is poised for continued innovation.
Opportunities lie in expanding markets, advancing technology, and improving surgical outcomes through collaboration.
Investments in industrial scale, automation, and platform advancements signal a strategic focus on future growth.

Intuitive Surgical (ISRG) reports robust Q1 performance and growth outlook

Intuitive Surgical (ISRG) delivered strong Q1 results with revenue up 14% and exceeding procedure growth expectations.
While facing challenges in manufacturing and supply chain, the company is focusing on R&D progress and inventory replenishment.
The outlook for 2023 looks promising with increased procedure growth forecasts and a focus on improving patient outcomes and market expansion.
Overall, Intuitive Surgical (ISRG) is well-positioned to capitalize on opportunities for growth and innovation in the robotic surgery market.

Intuitive Surgical excels in Q2 performance, eyes AI opportunities

Intuitive Surgical's Q2 2023 performance showcased strong revenue growth, procedure increases, and a focus on healthcare improvement.
The company's strengths include innovative ecosystem investments, commitment to patient outcomes, and advanced surgical technologies.
Challenges include market disruptions from new drugs, expense management, and adapting to changing healthcare landscapes.
Opportunities in AI, market expansion, and new procedures position Intuitive Surgical for continued growth and innovation.

Intuitive Surgical excels in Q3, eyes global expansion and margin growth

Intuitive Surgical's Q3 performance reflects strong growth and strategic focus on innovation and market expansion. Despite challenges in specific procedure categories and pricing dynamics, the company is well-positioned to capitalize on opportunities for growth and margin improvement.

Intuitive Surgical posts strong 2023 results, da Vinci 5 launch ahead

Intuitive Surgical's 2023 performance reflects strong revenue growth, operational excellence, and a strategic focus on innovation with the upcoming da Vinci 5 launch.
While facing challenges in operating margin pressure and supply chain issues, the company is well-positioned to capitalize on opportunities in soft tissue surgery, big data integration, and leased placements.
Investors should monitor how Intuitive Surgical navigates the launch of da Vinci 5, manages operational challenges, and leverages growth opportunities to sustain its market leadership.
Overall, Intuitive Surgical's Q4 earnings call highlights a resilient business model, customer-centric approach, and a commitment to advancing surgical technology for better patient outcomes.

Intuitive Surgical posts robust Q1 results amidst global market challenges

Intuitive Surgical delivered strong Q1 results with notable procedure and revenue growth, despite challenges in certain markets.
The company's focus on newer platforms, operational efficiency, and strategic outlook for 2024 positions it for continued success.
Addressing challenges and seizing opportunities in global markets and product innovation will be key for sustained growth and competitiveness.

Intuitive Surgical excels in Q2, eyes global expansion and innovation

Intuitive Surgical's Q2 performance reflects strength in procedure growth and system platform advancements.
The company's commitment to innovation and value creation positions them well for future success.
Challenges include sustaining margins and navigating market dynamics, while opportunities lie in expansion and innovation.
Overall, Intuitive Surgical's focus on growth, technology, and patient care sets a positive trajectory for the future.

Intuitive Surgical excels in Q3 with strong growth and innovation

Intuitive Surgical's Q3 2024 performance reflects a company in a strong position with notable achievements in procedures, financials, and technological advancements. While facing challenges in margin progression and international expansion, the company is well-positioned to leverage opportunities in innovation and customer insights.

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

McDonald's

The 3 Most Promising Ray Dalio Stocks to Own Now

AbbVie

Baxter

Stryker

Medtronic

Med tech has been on the skids for no fault of its own. It's not the industry's fault that price action was driven to a frothy bubble by COVID-inspired trading outlooks or that the market has normalized.

A Significant Reversal is in Sight for These 5 Med Tech Companies

NVIDIA

Progyny

Nvidia and artificial intelligence dominate recent headlines -- deservedly so. But there are many diverse companies getting bullish nods from Wall Street.

Wall Street Loves These 3 Growth Stocks; Should You?

UiPath

Teradyne

Among the long-term investment themes, robotics stocks are worth considering for multibagger returns. In the dynamic world when it comes to technology, robotics and artificial intelligence will play a key role across industries.

Don't Sleep on These 3 Robotics Stocks That Will Mint Millionaires

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

Intuitive Surgical, Inc. (ISRG) Is Considered a Good Investment by Brokers: Is That True?

Emerson Electric

Thermo Fisher Scientific

The world is becoming increasingly automated paving the way for robotics stocks moving forward. Sector growth is expected to reach double digits on an annualized basis and ranges from the low to mid-teens depending on the source In either case, capital invested in the sector has a reasonable chance of increasing in value.

3 Millionaire-Maker Robotics Stocks to Hold Through Thick and Thin

iRobot

For investors seeking opportunities, undervalued robotics stocks offer potential for significant gains in a rebounding high-growth sector. Depressed valuations have been driven by tech sell-offs due to rising rates and macro uncertainties.

3 Millionaire-Maker Robotics Stocks to Load Up Now

Honeywell

Rockwell Automation

Automation is a trend that's been ongoing for decades. As companies seek greater productivity, automating undesirable tasks will continue to happen, and AI and machine learning will help us get there.

Follow the Money: 3 Stocks to Buy to Ride the Automation Wave

Intuitive Surgical (ISRG) continues to raise optimism among investors, owing to its strength in robotics.

3 Reasons to Retain Intuitive Surgical (ISRG) in Your Portfolio

Intuitive Surgical's stock price has declined 18% in the past four weeks, offering a more attractive valuation. The decline in stock price is due to market expectations that companies benefiting from the side effects of obesity will lose long-term growth opportunities. ISRG remains a strong growth stock with efficient surgical systems and continued market share growth in weight-focused surgeries.

Intuitive Surgical: A Significantly Undervalued Healthcare Gem

Livanova

Pfizer

UnitedHealth Group

Viking Therapeutics

Zimmer Biomet Hlds

Zymeworks Inc

Investors always hope to buy low and sell high. In order to do so, it's necessary to identify stocks that are undervalued.

The 7 Most Undervalued Healthcare Stocks to Buy Now: August 2023

DexCom

Shockwave Medical

Wegovy and Mounjaro obesity and diabetes drugs are expected to have a significant impact on society and may lead to a decrease in demand for certain medical devices and surgeries. Medical device stocks, such as Shockwave, DexCom, and Intuitive Surgical, have experienced sell-offs due to concerns about the future impact of these drugs. However, there are still millions of overweight and obese individuals who will require medical interventions, creating potential opportunities for these stocks.

The Sell-Off Caused By Wegovy And Mounjaro In Medtech Stocks Offers A Huge Opportunity

Amazon

The global robotics industry is taking off, and investors are keeping a close eye on high-potential robotics stocks. Robotics and automation are going to transform the everyday lives of both humans and businesses.

3 Robotics Stocks You Better Be Buying on Each and Every Dip

Atmos Energy

Johnson & Johnson

Kimberly-Clark

PepsiCo

We have narrowed our search to five stocks from defensive sectors. These are: JNJ, PEP, ISRG, KMB, ATO.

5 Defensive Stocks for Stable Returns Amid Recent Volatility

Intuitive Surgical, the established leader in robotic surgery has lead recent advancements in AI that are incorporated into its existing robotic surgery offerings. Integration of AI technology in the company's robotic surgery systems could enhance precision, planning, monitoring, and training, leading to a potential growth surge of 20%. This could aid the company in defending its position against challengers, which we believe would lead to Intuitive gaining even more market share in the lucrative robotic surgical market.

Intuitive Surgical: AI Boosts Robotic Surgery Leadership

Advanced Micro Devices

Alphabet

Mastercard

Microsoft

With the digital innovation space kicking into high gear with advancements such as artificial intelligence, it might pay off to consider strong buy tech stocks. By definition, these enterprises represent publicly traded technology firms that enjoy a strong buy consensus view – or the equivalent.

7 ‘Strong Buy' Tech Stocks You Should Be Loading Up On Now

Zebra Technologies

Robotics is one of the most exciting and innovative sectors in the world today. This sector has the potential to transform various industries, particularly manufacturing and healthcare by creating new opportunities for growth and efficiency.

3 Robotics Stocks to Buy Before the Breakout

We have narrowed our search to five U.S. corporate behemoths. These are: META, GOOGL, ISRG, JNJ, PEP.

Fed's July Rate Hike and Comments Match Expectations: 5 Picks

Danaher

Eli Lilly

McKesson

Teladoc

Healthcare continues to be a major industry and economic driver around the world. According to the American Medical Association, spending on healthcare in the U.S. totals more than $4 trillion each year, which works out to nearly $13,000 per person.

7 Millionaire-Maker Healthcare Stocks to Buy Before the Window Closes

Artificial intelligence stocks have been soaring this year, but they're valued extremely expensively now. Recent earnings reports suggest the healthcare industry is experiencing strong growth.

AI Stocks Are Overpriced. The Next Big Growth Opportunity Could Instead Be in This Industry

Nauticus Robotics Inc

In the ever-evolving world of technology, robotics has emerged as a sector with immense potential. The quest for automation and efficiency has led to the development of some of the best robotics stocks to buy.

If You Can Only Buy One Robotics Stock, It Better Be One of These 3 Names

Intuit

Over the near term, the indices are likely to move higher, but an autumn correction looms. Here are a pair of stock recommendations, one long and one short.

Stocks This Week: Buy Intuit And Sell Short Intuitive Surgical

Exact Sciences

Exact Sciences develops innovative diagnostics tests that help intercept cancer early. Intuitive Surgical's famous robotic surgical system has important benefits for patients.

2 Revolutionary Stocks to Buy and Hold for 10 Years

Timing is everything. Intuitive Surgical, Inc. NASDAQ: ISRG delighted investors by beating revenue and earnings expectations when it reported second-quarter earnings after the market closed on July 20.

ISRG Stock Sinks After Strong Earnings: Is the Growth Priced In?

Intuitive Surgical (NASDAQ:ISRG) shares slipped on weaker demand for bariatric surgeries during the second quarter despite outperforming the Street's expectations on profit and sales. The company, which develops and manufactures robotic surgery solutions aimed at improving clinical outcomes, told investors on Thursday that it had seen waning demand for robot-assisted bariatric surgeries amid the rising popularity of obesity drugs, sending its shares lower.

News for Intuitive Surgical Stock (ISRG)